Sullivan Timothy Eugene 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Sullivan Timothy Eugene
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-22$30.43/sh−3,088$93,954→ 129,211 total
Holdings
- 70,396(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.
- [F2]The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.